AAME vs BODI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 30, 2026

AAME

40.6
AI Score
VS
BODI Wins

BODI

47.7
AI Score

Investment Advisor Scores

AAME

41score
Recommendation
HOLD

BODI

48score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AAME BODI Winner
Revenue 159.18M 54.28M AAME
Net Income 4.70M 2.29M AAME
Net Margin 2.9% 4.2% BODI
ROE 4.3% 6.7% BODI
ROA 1.1% 1.6% BODI
Total Assets 430.86M 143.13M AAME
Cash 34.44M 36.59M BODI
Free Cash Flow 14.73M -1.72M AAME

Relative Price Performance (Last 90 Days)

AAME 1M: -3.5% · 3M: -36.0% BODI 1M: -8.4% · 3M: -34.1%

Current Technical Phase

AAME

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.1 · Price: $1.65

BODI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -10.1%), weak momentum, RSI 42

RSI (14): 42.0 · Price: $9.88

Fundamentals Snapshot

Metric AAME BODI
Market Cap
Forward P/E 7.4 9.4
Trailing P/E 6.7 14.1
Revenue (TTM)
Revenue Growth 0.2% -0.3%
Gross Margin 0.1% 0.7%
Operating Margin 0.0% 0.1%
EPS 0.23 0.71
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, BODI is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.